Recent developments in drug targets and delivery of anti-HIV drugs

Infectious Disorders - Drug Targets

Volumn 6, Issue 2, 2006, Pages 107-119

  Salama, Noha N ^a   Endsley, Aaron ^a   Ho, Rodney J Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cellular targets; HAART; HIV; Selective delivery; Viral latency

Indexed keywords

ABACAVIR; AMDOXOVIR; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATAZANAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; ELVUCITABINE; EMTRICITABINE; ENFUVIRTIDE; INDINAVIR; INTEGRASE; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; NUCLEOSIDE ANALOG; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TARGETING; DRUG TISSUE LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; LYMPHATIC SYSTEM; NONHUMAN; REVIEW; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

ANTI-HIV AGENTS; DRUG DELIVERY SYSTEMS; HIV INFECTIONS; HUMANS; VIRUS LATENCY;

EID: 33745090541     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152606784112137     Document Type: Review

References (145)

1. http://www.avert.org/worldstats.htm.
2. http://www.unaids.org/wad2004/EPI_1204_pdf_en/Chapter01_intro_en.pdf.
3. Sereti, I.; Lane, H.C. Clin. Infect. Dis., 2001, 32, 1738.
4. Kahn, J.O.; Walker, B.D. N. Engl. J. Med., 1998, 339, 33.
5. Pitrak, D.L.; Sutton, S.H.; Tsai, H.C.; Mullane, K.M.; Pau, A.K. AIDS, 1999, 13, 427.
6. Cocchi, F.; DeVico, A.L.; Garzino-Demo, A.; Arya, S.K.; Gallo, R.C.; Lusso, P. Science, 1995, 270, 1811.
7. Koka, P.S.; Reddy, S.T. Curr. HIV Res., 2004, 2, 275.
8. de Clercq, E.D. Expert Opin. Emerg. Drugs, 2005, 10, 241.
9. WHO-UNAIDS. AIDS, 2001, 15(7), W27.
10. Moore, J.P.; Burton, D.R. Nat. Med., 2004, 10, 769.
11. Flynn, N.M.; Forthal, D.N.; Harro, C.D.; Judson, F.N.; Mayer, K.H.; Para, M.F. The rgp120 HIV Vaccine Study Group. J. Infect. Dis., 2005, 191, 654.
12. Shepherd, B.; Gilbert, P.; Gurwith, M.; Francis, D. Abstract in the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 2004, Abstract 284.
13. Mascola, J.R.; Lewis, M.G.; Stiegler, G.; Harris, D.; VanCott, T.C.; Hayes, D.; Louder, M.K.; Brown, C.R.; Sapan, C.V.; Frankel, S.S.; Lu, Y.; Robb, M.L.; Katinger, H.; Birx, D.L. J. Virol., 1999, 73, 4009.
14. Mascola, J.R.; Stiegler, G.; VanCott, T.C.; Katinger, H.; Carpenter, C.B.; Hanson, C.E.; Beary, H.; Hayes, D.; Frankel, S.S.; Birx, D.L.; Lewis, M.G. Nat. Med., 2000, 6, 207.
15. Baba, T.W.; Liska, V.; Hofmann-Lehmann, R.; Vlasak, J.; Xu, W.; Ayehunie, S.; Cavacini, L.A.; Posner, M.R.; Katinger, H.; Stiegler, G.; Bernacky, B.J.; Rizvi, T.A.; Schmidt, R.; Hill, L.R.; Keeling, M.E.; Lu, Y.; Wright, J.E.; Chou, T.C.; Ruprecht, R.M. Nat. Med., 2000, 6, 200.
16. Amara, R.R.; Villinger, F.; Altman, J.D.; Lydy, S.L.; O'Neil, S.P.; Staprans, S.I.; Montefiori, D.C.; Xu, Y.; Herndon, J.G.; Wyatt, L.S.; Candido, M.A.; Kozyr, N.L.; Earl, P.L.; Smith, J.M.; Ma, H.L.; Grimm, B.D.; Hulsey, M.L.; Miller, J.; McClure, H.M.; McNicholl, J.M.; Moss, B.; Robinson, H.L. Science, 2001, 292, 69.
17. Schmitz, J.E.; Kuroda, M.J.; Santra, S.; Sasseville, V.G.; Simon, M.A.; Lifton, M.A.; Racz, P.; Tenner-Racz, K.; Dalesandro, M.; Scallon, B.J.; Ghrayeb, J.; Forman, M.A.; Montefiori, D.C.; Rieber, E.P.; Letvin, N.L.; Reimann, K.A. Science, 1999, 283, 857.
18. Leung, L.; Srivastava, I.K.; Kan, E.; Legg, H.; Sun, Y.; Greer, C.; Montefiori, D.C.; zur Megede, J.; Barnett, S.W. AIDS, 2004, 18, 991.
19. Devico, A.L.; Fouts, T.R.; Shata, M.T.; Kamin-Lewis, R.; Lewis, G.K.; Hone, D.M. Vaccine, 2002, 20, 1968.
20. Palella, F.J.J.; Delaney, K.M.; Moorman, A.C.; Loveless, M.O.; Fuhrer, J.; Satten, G.A.; Aschman, D.J.; Holmberg, S.D. N. Engl. J. Med., 1998, 338, 853.
21. Cooper, E.R.; Charurat, M.; Mofenson, L.; Hanson, I.C.; Pitt, J.; Diaz, C.; Hayani, K.; Handelsman, E.; Smeriglio, V.; Hoff, R.; Blattner, W.; Women and Infants' Transmission Study Group. J. Acquir. Immune Defic. Syndr., 2002, 29, 484.
22. Fowler, M.G.; Simonds, R.J.; Roongpisuthipong, A. Pediatr. Clin. North Am., 2000, 47, 21.
23. http://www.sfaf.org/aboutsfaf/outreach/november97/beta_briefs_nov97.html.
24. Roge, B.T.; Barfod, T.S.; Kirk, O.; Katzenstein, T.L.; Obel, N.; Nielsen, H.; Pedersen, C.; Mathiesen, L.R.; Lundgren, J.D.; Gerstoft, J. HIV Med., 2004, 5, 344.
25. Walmsley, S.; Bernstein, B.; King, M.; Arribas, J.; Beall, G.; Ruane, P.; Johnson, M.; Johnson, D.; Lalonde, R.; Japour, A.; Brun, S.; Sun, E. N. Engl. J. Med., 2002, 346, 2039.
26. Squires, K.E.; Thiry, A. Giordano, M. Abstract in the 42nd Interscience Congress on Antimicrobial Agents and Chemotherapy, San Diego, CA, 2002, Abstract H-1076.
27. Fischl, M.A.; Castro, J.; Monroig, R.; Scerpella, E.; Thompson, L.; Rechtine, D.; Thomas, D. Abstract in the 8th conference on Retroviruses and Opportunistic Infections, Chicago, IL, 2001, Abstract 528.
28. van Leeuwen, R.; Katlama, C.; Murphy, R.L.; Squires, K.; Gatell, J.; Horban, A.; Clotet, B.; Staszewski, S.; van Eeden, A.; Clumeck, N.; Moroni, M.; Pavia, A.T.; Schmidt, R.E.; Gonzalez-Lahoz, J.; Montaner, J.; Antunes, F.; Gulick, R.; Banhegyi, D.; van der Valk, M.; Reiss, P.; van Weert, L.; van Leth, F.; Johnson, V.A.; Sommadossi, J.P.; Lange, J.M. AIDS, 2003, 17, 987.
29. Hamer, D.H. Curr. HIV Res., 2004, 2, 99.
30. Wong, J.K.; Gunthard, H.F.; Havlir, D.V.; Zhang, Z.Q.; Haase, A.T.; Ignacio, C.C.; Kwok, S.; Emini, E.; Richman, D.D. Proc. Natl. Acad. Sci. USA, 1997, 94, 12574.
31. Wong, J.K.; Hezarech, M.; Gunthard, H.F.; Havlir, D.V.; Ignacio, C.C.; Spina, C.A.; Richman, D.D. Science, 1997, 278, 1291.
32. Kinman, L.; Brodie, S.J.; Tsai, C.C.; Bui, T.; Larsen, K.; Schmidt, A.; Anderson, D.; Morton, W.R.; Hu, S.L.; Ho, R.J. J. Acquir. Immune Defic. Syndr., 2003, 34, 387.
33. Eron, J.J.; Vernazza, P. AIDS, 2001, 15, S161.
34. Dutschman, G.E.; Grill, S.P.; Gullen, E.A.; Haraguchi, K.; Takeda, S.; Tanaka, H.; Baba, M.; Cheng, Y.C. Antimicrob. Agents Chemother., 2004, 48, 1640.
35. Otto, M.J. Curr. Opin. Pharmacol., 2004, 4, 431.
36. De Clercq, E.D. Antiviral Res., 2005, 67, 56.
37. Geleziunas, R.; Gallagher, K.; Zhang, H.; Bacheler, L.; Garber, S.; Wu, J.T.; Shi, G.; Otto, M.J.; Schinazi, R.F.; Erickson-Viitanen, S. Antivir. Chem. Chemother., 2003, 14, 49.
38. Garvey, E.P. Curr. Drug Targets Infect. Disord., 2001, 1, 107.
39. Sanne, I.; Mommeja-Marin, H.; Hinkle, J.; Bartlett, J.A.; Lederman, M.M.; Maartens, G.; Wakeford, C.; Shaw, A.; Quinn, J.; Gish, R.G.; Rousseau, F. J. Infect. Dis., 2005, 191, 825.
40. Kucera, G.L.; Goff, C.L.; Iyer, N.; Morris-Natschke, S.; Ishaq, K.S.; Wyrick, S.D.; Fleming, R.A.; Kucera, L.S. Antiviral Res., 2001, 50, 129.
41. Krugner-Higby, L.; Goff, D.; Edwards, T.; Iyer, N.; Neufeld, J.; Kute, T.; Morris-Natschke, S.; Ishaq, K.; Piantadosi, C.; Kucera, L.S. AIDS Res. Hum. Retroviruses, 1995, 11, 705.
42. Daniel, L.W.; Etkin, L.A.; Morrison, B.T.; Parker, J.; Morris-Natschke, S.; Surles, J.R.; Piantadosi, C. Lipids, 1987, 22, 851.
43. Daniel, L.W.; Small, G.W.; Schmitt, J.D.; Marasco, C.J.; Ishaq, K.; Piantadosi, C. Biochem. Biophys. Res. Commun., 1988, 151, 291.
44. Fields, A.P.; Bednarik, D.P.; Hess, A.; May, W.S. Nature, 1988, 333, 278.
45. Cundy, K.C.; Barditch-Crovo, P.; Walker, R.E.; Collier, A.C.; Ebeling, D.; Toole, J.; Jaffe, H.S. Antimicrob. Agents Chemother., 1995, 39, 2401.
46. Rossi, L.; Serafini, S.; Cappellacci, L.; Balestra, E.; Brandi, G.; Schiavano, G.F.; Franchetti, P.; Grifantini, M.; Perno, C.F.; Magnani, M. J. Antimicrob. Chemother., 2001, 47, 819.
47. De Clerq, E. Antiviral Res., 1998, 38, 138.
48. Mehandru, S.; Markowitz, M. Expert Opin. Investig. Drugs, 2003, 12, 1821.
49. Hawes, J. BETA, 2004, 16, 13.
50. Robinson, B.S.; Riccardi, K.A.; Gong, Y.F.; Guo, Q.; Stock, D.A.; Blair, W.S.; Terry, B.J.; Deminie, C.A.; Djang, F.; Colonno, R.J.; Lin, P.F. Antimicrob. Agents Chemother., 2000, 44, 2093.
51. Goldsmith, D.R.; Perry, C.M. Drugs, 2003, 63, 1679.
52. Surleraux, D.L.; Tahri, A.; Verschueren, W.G.; Pille, G.M.; de Kock, H.A.; Jonckers, T.H.; Peeters, A.; De Meyer, S.; Azijn, H.; Pauwels, R.; de Bethune, M.P.; King, N.M.; Prabu-Jeyabalan, M.; Schiffer, C.A.; Wigerinck, P.B. J. Med. Chem., 2005, 48, 1813.
53. De Meyer, S.; Azijn, H.; Surleraux, D.; Jochmans, D.; Tahri, A.; Pauwels, R.; Wigerinck, P.; de Bethune, M.P. Antimicrob. Agents Chemother., 2005, 49, 2314.
54. LaFemina, R.L.; Schneider, C.L.; Robbins, H.L.; Callahan, P.L.; LeGrow, K.; Roth, E.; Schleif, W.A.; Emini, E.A. J. Virol., 1992, 66, 7414.
55. Pommier, Y.; Marchand, C.; Neamati, N. Antiviral Res., 2000, 47, 139.
56. Pluymers, W.; Neamati, N.; Pannecouque, C.; Fikkert, V.; Marchand, C.; Burke, T.R.J.; Pommier, Y.; Schols, D.; De Clercq, E.; Debyser, Z.; Witvrouw, M. Mol. Pharmacol., 2000, 58, 641.
57. Este, J.A.; Cabrera, C.; Schols, D.; Cherepanov, P.; Gutierrez, A.; Witvrouw, M.; Pannecouque, C.; Debyser, Z.; Rando, R.F.; Clotet, B.; Desmyter, J.; De Clercq, E. Mol. Pharmacol., 1998, 53, 340.
58. Wai, J.S.; Egbertson, M.S.; Payne, L.S.; Fisher, T.E.; Embrey, M.W.; Tran, L.O.; Melamed, J.Y.; Langford, H.M.; Guare, J.P.J.; Zhuang, L.; Grey, V.E.; Vacca, J.P.; Holloway, M.K.; Naylor-Olsen, A.M.; Hazuda, D.J.; Felock, P.J.; Wolfe, A.L.; Stillmock, K.A.; Schleif, W.A.; Gabryelski, L.J.; Young, S.D. J. Med. Chem., 2000, 43, 4923.
59. Shiomi, K.; Matsui, R.; Isozaki, M.; Chiba, H.; Sugai, T.; Yamaguchi, Y.; Masuma, R.; Tomoda, H.; Chiba, T.; Yan, H.; Kitamura, Y.; Sugiura, W.; Omura, S.; Tanaka, H. J. Antibiot. (Tokyo), 2005, 58, 65.
60. Billich, A. Curr. Opin. Investig. Drugs, 2003, 4, 206.
61. http://www.aidsinfonyc.org/tag/tx/CROI2003Pipeline.html.
62. Fikkert, V.; Hombrouck, A.; Van Remoortel, B.; De Maeyer, M.; Pannecouque, C.; De Clercq, E.; Debyser, Z.; Witvrouw, M. AIDS, 2004, 18, 2019.
63. Li, F.; Goila-Gaur, R.; Salzwedel, K.; Kilgore, N.R.; Reddick, M.; Matallana, C.; Castillo, A.; Zoumplis, D.; Martin, D.E.; Orenstein, J.M.; Allaway, G.P.; Freed, E.O.; Wild, C.T. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 13555.
64. http://www.vitechnologies.com/product_2.htm.
65. http://www.mitsuivp.com/cgi-bin/WebObjects/f1f2557f0f.woa/wa/read/ 1014d6debfa/.
66. Tang, C.; Loeliger, E.; Kinde, I.; Kyere, S.; Mayo, K.; Barklis, E.; Sun, Y.; Huang, M.; Summers, M.F. J. Mol. Biol., 2003, 327, 1013.
67. Teng, B.; Burant, C.F.; Davidson, N.O. Science, 1993, 260, 1816.
68. Jarmuz, A.; Chester, A.; Bayliss, J.; Gisbourne, J.; Dunham, I.; Scott, J.; Navaratnam, N. Genomics, 2002, 79, 285.
69. Harris, R.S.; Bishop, K.N.; Sheehy, A.M.; Craig, H.M.; Petersen- Mahrt, S.K.; Watt, I.N.; Neuberger, M.S.; Malim, M.H. Cell, 2003, 113, 803.
70. An, P.; Bleiber, G.; Duggal, P.; Nelson, G.; May, M.; Mangeat, B.; Alobwede, I.; Trono, D.; Vlahov, D.; Donfield, S.; Goedert, J.J.; Phair, J.; Buchbinder, S.; O'Brien, S.J.; Telenti, A.; Winkler, C.A. J. Virol., 2004, 78, 11070.
71. Pierson, T.C.; Doms, R.W. Curr. Top. Microbiol. Immunol., 2003, 281, 1.
72. Lazzarin, A.; Clotet, B.; Cooper, D.; Reynes, J.; Arasteh, K.; Nelson, M.; Katlama, C.; Stellbrink, H.J.; Delfraissy, J.F.; Lange, J.; Huson, L.; DeMasi, R.; Wat, C.; Delehanty, J.; Drobnes, C.; Salgo, M.; TORO 2 Study Group. N. Engl. J. Med., 2003, 348, 2186.
73. Lalezari, J.P.; Henry, K.; O'Hearn, M.; J.S., M.; P.J., P.; Trottier, B.; Walmsley, S.; Cohen, C.; Kuritzkes, D.R.; Eron, J.J.J.; Chung, J.; DeMasi, R.; Donatacci, L.; Drobnes, C.; Delehanty, J.; Salgo, M.; TORO 1 Study Group. N. Engl. J. Med., 2003, 348, 2175.
74. Duffalo, M.L.; James, C.W. Ann. Pharmacother., 2003, 37, 1448.
75. Kilby, J.M.; Eron, J.J. N. Engl. J. Med., 2003, 348, 2228.
76. Clapham, P.R.; McNight, A. J. Gen. Virol., 2002, 83, 1809.
77. Rusconi, S.; Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. Curr. Drug Targets Infect. Disord., 2004, 4, 339.
78. Wang, H.G.; Williams, R.E.; Lin, P.F. Curr. Pharm. Des., 2004, 10, 1785.
79. Jing, N.; Xu, X. Curr. Drug Targets Infect. Disord., 2001, 1, 79.
80. McCaffrey, A.P.; Meuse, L.; Pham, T.T.; Conklin, D.S.; Hannon, G.J.; Kay, M.A. Nature, 2002, 418, 38.
81. Akkina, R.; Banerjea, A.; Bai, J.; Anderson, J.; Li, M.J.; Rossi, J. Anticancer Res., 2003, 23, 1997.
82. Banerjea, A.; Li, M.J.; Bauer, G.; Remling, L.; Lee, N.S.; Rossi, J.; Akkina, R. Mol. Ther., 2003, 8, 62.
83. Lysik, M.A.; Wu-Pong, S. J. Pharm. Sci., 2003, 92, 1559.
84. Morris, M.C.; Vidal, P.; Chaloin, L.; Heitz, F.; Divita, G. Nucleic Acids Res., 1997, 25, 2730.
85. Proudfoot, A.E.I.; Wells, T.N.C.; Clapham, P.R. Biochem. Pharmacol., 1999, 57, 451.
86. Scozzafava, A.; Mastrolorenzo, A.; Supuran, C.T. J. Enzyme Inhib. Med. Chem., 2002, 17, 69.
87. Blanpain, C.; Libert, F.; Vassart, G.; Parmentier, M. Receptors Channels, 2002, 8, 19.
88. Baba, M.; Nishimura, O.; Kanzaki, N.; Okamoto, M.; Sawada, H.; Iizawa, Y.; Shiraishi, M.; Aramaki, Y.; Okonogi, K.; Ogawa, Y.; Meguro, K.; Fujino, M. Proc. Natl. Acad. Sci. USA, 1999, 96, 5698.
89. Coffield, V.M.; Jiang, Q.; Su, L. Nat. Biotechnol., 2003, 21, 1321.
90. Yap, M.W.; Nisole, S.; Lynch, C.; Stoye, J.P. Proc. Natl. Acad. Sci. USA, 2004, 101, 10786.
91. Stremlau, M.; Owens, C.M.; Perron, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J. Nature, 2004, 427, 848.
92. Harris, M.E.; Hope, T.J. Essays Biochem., 2000, 36, 115.
93. Cullen, B.R. J. Cell Sci., 2003, 116, 587.
94. Yedavalli, V.S.; Neuveut, C.; Chi, Y.H.; Kleiman, L.; Jeang, K.T. Cell, 2004, 119, 381.
95. Agbottah, E.; de La Fuente, C.; Nekhai, S.; Barnett, A.; Gianella-Borradori, A.; Pumfery, A.; Kashanchi, F. J. Biol. Chem., 2005, 280, 3029.
96. Engelman, A.; Englund, G.; Orenstein, J.M.; Martin, M.A.; Craigie, R. J. Virol., 1995, 69, 2729.
97. Wu, X.; Liu, H.; Xiao, H.; Conway, J.A.; Hehl, E.; Kalpana, G.V.; Prasad, V.; Kappes, J.C. J. Virol., 1999, 73, 2126.
98. Pluymers, W.; De Clerq, E.; Debyser, Z. Curr. Drug Targets Infect. Disord., 2001, 1, 133.
99. Arya, D.P.; Coffee, R.L.; Charles, I. J. Am. Chem. Soc., 2001, 123, 11093.
100. Ren, J.; Qu, X.; Dattagupta, N.; Chaires, J.B. J. Am. Chem. Soc., 2001, 123, 6742.
101. Saenger, W. Principles of Nucleic Acid Structure. Springer-Verlag: New York, 1983.
102. Happ, C.S.; Happ, E.; Clore, G.M.; Gronenborn, A.M. FEBS Lett., 1988, 236, 62.
103. Barbieri, C.M.; Li, T.K.; Guo, S.; Wang, G.; Shallop, A.J.; Pan, W.; Yang, G.; Gaffney, B.L.; Jones, R.A.; Pilch, D.S. J. Am. Chem. Soc., 2003, 125, 6469.
104. Li, T.K.; Barbieri, C.M.; Lin, H.C.; Rabson, A.B.; Yang, G.; Fan, Y.; Gaffney, B.L.; Jones, R.A.; Pilch, D.S. Biochemistry, 2004, 43, 9732.
105. Blankson, J.N.; Persaud, D.; Siliciano, R.F. Annu. Rev. Med., 2002, 53, 557.
106. Reinhardt, R.L.; Khoruts, A.; Merica, R.; Zell, T.; Jenkins, M.K. Nature, 2001, 410, 101.
107. Pomerantz, R.J. AIDS, 2001, 15, 1201.
108. Schrager, L.K.; D'Souza, M.P. JAMA, 1998, 280, 67.
109. Huisman, M.T.; Smit, J.W.; Schinkel, A.H. AIDS, 2000, 14, 237.
110. Siliciano, J.D.; Kajdas, J.; Finzi, D.; Quinn, T.C.; Chadwick, K.; Margolick, J.B.; Kovacs, C.; Gange, S.J.; Siliciano, R.F. Nat. Med., 2003, 9, 727.
111. Swingler, S.; Brichacek, B.; Jacque, J.M.; Ulich, C.; Zhou, J.; Stevenson, M. Nature, 2003, 424, 213.
112. Koenig, S.; Gendelman, H.E.; Orenstein, J.M.; Dal Canto, M.C.; Pezeshkpour, G.H.; Yungbluth, M.; Janotta, F.; Aksamit, A.; Martin, M.A.; Fauci, A.S. Science, 1986, 233, 1089.
113. Meltzer, M.S.; Nakamura, M.; Hansen, B.D.; Turpin, J.A.; Kalter, D.C.; Gendelman, H.E. AIDS Res. Hum. Retroviruses, 1990, 6, 967.
114. Crowe, S.M.; Mills, J.; Kirihara, J.; Boothman, J.; Marshall, J.A.; McGrath, M.S. AIDS Res. Hum. Retroviruses, 1990, 6, 1031.
115. Herbein, G.; Van Lint, C.; Lovett, J.L.; Verdin, E. J. Virol., 1998, 72, 660.
116. Mastino, A.; Grelli, S.; Piacentini, M.; Oliverio, S.; Favalli, C.; Perno, C.F.; Garci, E. Cell Immunol., 1993, 152, 120.
117. Swingler, S.; Mann, A.; Jacque, J.; Brichacek, B.; Sasseville, V.G.; Williams, K.; Lackner, A.A.; Janoff, E.N.; Wang, R.; Fisher, D.; Stevenson, M. Nat. Med., 1999, 5, 97.
118. Kulkosky, J.; Pomerantz, R.J. Clin. Infect. Dis., 2002, 35, 1520.
119. Mocroft, A.; Vella, S.; Benfield, T.L.; Chiesi, A.; Miller, V.; Gargalianos, P.; d'Arminio Monforte, A.; Yust, I.; Bruun, J.N.; Phillips, A.N.; Lundgren, J.D. Lancet, 1998, 352, 1725.
120. Solas, C.; Lafeuillade, A.; Halfon, P.; Chadapaud, S.; Hittinger, G.; Lacarelle, B. Antimicrob. Agents Chemother., 2003, 47, 238.
121. Ruiz, L.; van Lunzen, J.; Arno, A.; Stellbrink, H.J.; Schneider, C.; Rull, M.; Castella, E.; Ojanguren, I.; Richman, D.D.; Clotet, B.; Tenner-Racz, K.; Racz, P. AIDS, 1999, 13, F1.
122. Lian, T.; Ho, R.J. J. Pharm. Sci., 2001, 90, 667.
123. Lin, J.H.; Chen, I.W.; Vastag, K.J.; Ostovic, D. Drug Metab. Dispos., 1995, 23, 730.
124. Levy, R.M.; Bredesen, D.E.; Rosenblum, M.L. J. Neurosurg., 1985, 62, 475.
125. Price, R.W.; Brew, B.; Sidtis, J.; Rosenblum, M.; Scheck, A.C.; Cleary, P. Science, 1988, 239, 586.
126. Gimenez, F.; Fernandez, C.; Mabondzo, A. J. Acquir. Immune Defic. Syndr., 2004, 36, 649.
127. Kim, R.B.; Fromm, M.F.; Wandel, C.; Leake, B.; Wood, A.J.; Roden, D.M.; Wilkinson, G.R. J. Clin. Invest., 1998, 101, 289.
128. Salama, N.N.; Kelly, E.J.; Bui, T.; Ho, R.J. J. Pharm. Sci., 2005, 94, 1216.
129. Choo, E.F.; Leake, B.; Wandel, C.; Imamura, H.; Wood, A.J.; Wilkinson, G.R.; Kim, R.B. Drug Metab. Dispos., 2000, 28, 655.
130. Kinman, L.M.; Worlein, J.M.; Leigh, J.; Bielefeldt-Ohmann, H.; Anderson, D.M.; Hu, S.L.; Morton, W.R.; Anderson, B.D.; Ho, R.J. AIDS, 2004, 18, 1363.
131. Worlein, J.M.; Leigh, J.; Larsen, K.; Kinman, L.; Schmidt, A.; Ochs, H.; Ho, R.J. J. Neurovirol., 2005, 11, 34.
132. Kedzierska, K.; Crowe, S.M. Curr. Med. Chem., 2002, 9, 1893.
133. Gartner, S.; Markovits, P.; Markovitz, D.M.; Kaplan, M.H.; Gallo, R.C.; Popovic, M. Science, 1986, 233, 215.
134. Schubert, U.; Ott, D.E.; Chertova, E.N.; Welker, R.; Tessmer, U.; Princiotta, M.F.; Bennink, J.R.; Krausslich, H.G.; Yewdell, J.W. Proc. Natl. Acad. Sci. USA, 2000, 97, 13057.
135. Magnani, M.; Rossi, L.; Brandi, G.; Schiavano, G.F.; Montroni, M.; Piedimonte, G. Proc. Natl. Acad. Sci. USA, 1992, 89, 6477.
136. Rossi, L.; Brandi, G.; Fraternale, A.; Schiavano, G.F.; Chiarantini, L.; Magnani, M. J. Acquir. Immune Defic. Syndr., 1993, 6, 1179.
137. Magnani, M.; Rossi, L.; Fraternale, A.; Silvotti, L.; Quintavalla, F.; Piedimonte, G.; Matteucci, D.; Baldinotti, F.; Bendinelli, M. AIDS Res. Hum. Retroviruses, 1994, 10, 1179.
138. Fraternale, A.; Tonelli, A.; Casabianca, A.; Vallanti, G.; Chiarantini, L.; Schiavano, G.F.; Benatti, U.; De Flora, A.; Magnani, M. J. Acquir. Immune Defic. Syndr., 1999, 21, 81.
139. Millan, C.G.; Marinero, M.L.; Castaneda, A.Z.; Lanao, J.M. J. Control. Release, 2004, 95, 27.
140. Rinaldo, C.R.J.; Huang, X.L.; Fan, Z.; Margolick, J.B.; Borowski, L.; Hoji, A.; Kalinyak, C.; McMahon, D.K.; Riddler, S.A.; Hildebrand, W.H.; Day, R.B.; Mellors, J.W. J. Virol., 2000, 74, 4127.
141. Benito, J.M.; Lopez, M.; Lozano, S.; Martinez, P.; Gonzalez-Lahoz, J.; Soriano, V. AIDS Res. Hum. Retroviruses, 2004, 20, 227.
142. Benito, J.M.; Lopez, M.; Soriano, V., AIDS Rev., 2004, 6, 79.
143. Cui, Z.; Patel, J.; Tuzova, M.; Ray, P.; Phillips, R.; Woodward, J.G.; Nath, A.; Mumper, R.J. Vaccine, 2004, 22, 2631.
144. Wang, H.Y.; Fu, T.; Wang, G.; Zeng, G.; Perry-Lalley, D.M.; Yang, J.C.; Restifo, N.P.; Hwu, P.; Wang, R.F. J. Clin. Invest., 2002, 109, 1463.
145. Singh, B.; Charkowicz, D.; Mascarenhas, D. J. Biol. Chem., 2004, 279, 477.